CDR-84189-41782
3 vaccinations
5 coded responses
30 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Pfizer-BioNTech
- 2020-12-26
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
- 2021-01-16
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
-
2021-01-30
Survey response — day 14, dose 2MedDRA: Menstruation delayed — Feeling: GoodFree text: I was 10 days late on my menstrual period. This has never happened to me before except when I was pregnant. This has happened to a lot of women and I think it should be looked at more closely.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-14
- 2021-02-26
- 2021-07-21
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Tenderness — Feeling: Fair · Site: Pain · Be unable to do your normal daily activitiesFree text: Very tender Axillary LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Still some lymphadenopathy to axillaryMedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-23
- 2021-10-30
-
2021-11-08
Survey response — day 35, dose 3MedDRA: Heavy menstrual bleeding, Menstruation delayed, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I had a brief very heavy period 1 week after booster. I am now late on my next period by 5 days. I have been to my ob/GYN for this. I'm not pregnant and thyroid is ok. My cycles have always been regular every 25-27 days.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-09
-
2021-11-09
Call successfulParticipant prefers to complete VAERS report online
- 2021-11-13
- 2022-01-01
- 2022-10-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of appetite
Release 3 — day 14, dose 2
Symptoms: I was 10 days late on my menstrual period. This has never happened to me before except when I was pregnant. This has happened to a lot of women and I think it should be looked at more closely.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Very tender Axillary Lymphadenopathy
Systemic reaction (other): Still some lymphadenopathy to axillary
Release 10 — day 35, dose 3
Symptoms: I had a brief very heavy period 1 week after booster. I am now late on my next period by 5 days. I have been to my ob/GYN for this. I'm not pregnant and thyroid is ok. My cycles have always been regular every 25-27 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release